Drug Development for Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (ME/CFS)
FDA will be planning a series of activities focused on drug development to treat the symptoms of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome (ME/CFS) in order to explore:
- The burden of disease that impacts the quality of life for ME/CFS patients;
- The quantitative outcome measures or endpoints that determine if disease symptoms improve with intervention; and
- How drug efficacy should be clinically tested based on these endpoints or measurements.
5 comments:
Thanks Dr Speedy.
Hope you are doing ok today Dr Speedy-I think Lipkin will find something in his own research soon enough!-Hilary
Hope you are feeling better, Dr. Speedy..I am encouraged by your continuing to fight for ME, love, Hope
Sadly, there can be no help for those of us with ME, Ramsey/Hyde, so long as FDA collapses the diagnoses of CFS and ME, as NIH just did,"The disabling disorder known as chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME)"
Lipkin, 2012. Drugs for people with fatigue will not help ME, in fact might harm us as they will not be tested on an ME patient population.
Recently, the only way I can get medical treatment of my classic case of acute, infectious onset ME, is by my doctors' using the more inclusive diagnosis of Viral encephalitis, then listing other specific diagnoses. Fortunately I have no history of any psychiatric disorder. The NHS would categorise my ME as CFS/ME, refuse medical testing and send me to the psychiatrists who insist on GET and CBT.
Post a Comment